Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial.
Saved in:
| Title: | Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial. |
|---|---|
| Authors: | Wilkinson AL; US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: lxq6@cdc.gov., Zaman K; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Hoque M; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Estivariz CF; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Burns CC; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Konopka-Anstadt JL; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Mainou BA; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Kovacs SD; US Centers for Disease Control and Prevention, Atlanta, GA, USA., An Q; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Lickness JS; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Yunus M; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Snider CJ; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Zhang Y; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Coffee E; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Abid T; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Wassilak SGF; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Pallansch MA; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Oberste MS; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Vertefeuille JF; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Anand A; US Centers for Disease Control and Prevention, Atlanta, GA, USA. |
| Source: | The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Sep; Vol. 23 (9), pp. 1062-1071. Date of Electronic Publication: 2023 May 10. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't; Equivalence Trial |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
